CRISPR Technology Shows Promise in Inhibiting Hepatitis E Virus
In a groundbreaking development that could redefine antiviral therapy, researchers have engineered a CRISPR-Cas13d based system to combat hepatitis E virus (HEV) infection with remarkable specificity and efficacy. Unlike the widely...
Read moreDetails






















